U.S. flag

An official website of the United States government

NM_000372.5(TYR):c.140G>A (p.Gly47Asp) AND Tyrosinase-negative oculocutaneous albinism

Germline classification:
Pathogenic (4 submissions)
Last evaluated:
Jul 22, 2021
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000003997.11

Allele description [Variation Report for NM_000372.5(TYR):c.140G>A (p.Gly47Asp)]

NM_000372.5(TYR):c.140G>A (p.Gly47Asp)

Gene:
TYR:tyrosinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q14.3
Genomic location:
Preferred name:
NM_000372.5(TYR):c.140G>A (p.Gly47Asp)
HGVS:
  • NC_000011.10:g.89178093G>A
  • NG_008748.1:g.5222G>A
  • NM_000372.5:c.140G>AMANE SELECT
  • NP_000363.1:p.Gly47Asp
  • NC_000011.9:g.88911261G>A
  • NM_000372.4:c.140G>A
  • P14679:p.Gly47Asp
Protein change:
G47D; GLY47ASP
Links:
UniProtKB: P14679#VAR_007652; OMIM: 606933.0024; dbSNP: rs61753180
NCBI 1000 Genomes Browser:
rs61753180
Molecular consequence:
  • NM_000372.5:c.140G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Tyrosinase-negative oculocutaneous albinism (OCA1A)
Synonyms:
Oculocutaneous albinism type 1A; Albinism, oculocutaneous, type IA
Identifiers:
MONDO: MONDO:0008745; MedGen: C4551504; Orphanet: 352731; Orphanet: 79431; OMIM: 203100

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000024163OMIM
no assertion criteria provided
Pathogenic
(Nov 15, 2008)
germlineliterature only

PubMed (3)
[See all records that cite these PMIDs]

SCV000597781Genetic Services Laboratory, University of Chicago
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Dec 14, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000998906Pele Pequeno Principe Research Institute, Faculdades Pequeno Principe
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicgermlineresearch

PubMed (1)
[See all records that cite this PMID]

SCV001821919Genome-Nilou Lab
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jul 22, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
Caucasiangermlineyesnot providednot providednot providednot providednot providedresearch

Citations

PubMed

Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.

Tripathi RK, Strunk KM, Giebel LB, Weleber RG, Spritz RA.

Am J Med Genet. 1992 Jul 15;43(5):865-71.

PubMed [citation]
PMID:
1642278

A frequent tyrosinase gene mutation associated with type I-A (tyrosinase-negative) oculocutaneous albinism in Puerto Rico.

Oetting WS, Witkop CJ Jr, Brown SA, Colomer R, Fryer JP, Bloom KE, King RA.

Am J Hum Genet. 1993 Jan;52(1):17-23.

PubMed [citation]
PMID:
8434585
PMCID:
PMC1682128
See all PubMed Citations (4)

Details of each submission

From OMIM, SCV000024163.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (3)

Description

See Tripathi et al. (1992) for the GGC(gly)-to-GAC(asp) mutation at codon 47. Oetting et al. (1993) found this mutation to be frequent among albinos in Puerto Rico. They found the G47D mutation in homozygous state in 9 of 12 unrelated Puerto Ricans with type IA oculocutaneous albinism (OCA1A; 203100). Two other individuals were heterozygous for the mutation; 1 of these had the T373K mutation (606933.0003) in the homologous allele. One of the individuals with Negroid features was homozygous for a W236X mutation (606933.0035). Because of the migration between Puerto Rico and the Canary Islands, 3 persons with OCA from the Canary Islands were analyzed. One was a genetic compound for the G47D mutation and a novel L216M mutation (606933.0036), one was homozygous for the P81L mutation (606933.0002), and one was heterozygous for the P81L mutation. Haplotype analysis in the Puerto Rican cases showed that the G47D mutation occurred on a single haplotype, consistent with a common ancestor for all individuals having this mutation. Two different haplotypes were found associated with the P81L mutation, suggesting that this may be either a recurring mutation for the tyrosinase gene or a recombination between haplotypes.

Chiang et al. (2008) reported a Hispanic family in which 2 sibs had variable manifestations of OCA1B (606952). A 6-year-old boy had nystagmus, decreased vision, light hair, light skin color, and foveal hypoplasia. His sister had exotropia, blonde hair, light skin color, and brown irides with no history of nystagmus, foveal hypoplasia or decreased vision. Genetic analysis identified compound heterozygosity for 2 variants in the TYR gene: G47D and the hypomorphic allele R402Q (606933.0009). Each unaffected parent was heterozygous for 1 of the variants. Chiang et al. (2008) postulated that the clinical spectrum of OCA depends on a pigmentation threshold of the affected individual, and that OCA is a quantitative trait disorder with phenotypic variation in individuals of different ethnic backgrounds.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Genetic Services Laboratory, University of Chicago, SCV000597781.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Pele Pequeno Principe Research Institute, Faculdades Pequeno Principe, SCV000998906.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Caucasiannot providednot providednot providedresearch PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Genome-Nilou Lab, SCV001821919.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024